2CRSi announces the launch of a €8 to €12 million round of financing to accelerate its growth in the Artificial Intelligence server market

The fund-raising, based on a target amount of around €8 million, which can be increased to around €12 million if there is sufficient demand, should provide 2CRSi with additional equity to increase its sales of servers for artificial intelligence (AI), by securing its supplies of NVIDIA components to equip servers.

This market, in which 2CRSi enjoys international recognition, is being driven by an explosion in global demand for high-performance server technology solutions and hosted computing power. As a result, a new development cycle has begun for 2CRSi, characterised by an acceleration in billings and an increase in order intake over the last few months.

Accordingly, consolidated revenue (unaudited) for the period from March 1, 2023 to February 29, 2024 amounted to €98 million, including €31.3 million invoiced in February alone. As of February 29, 2024, the order backlog stood at a record €47 million, to be invoiced before the end of the current fiscal year (June 30, 2024). These figures do not include the impact of the US contract, with a total value of $610 million, for which invoicing will begin in fiscal year 2024/25, nor do they include Green Data.

This solid momentum confirms the targets set for the current 16-month financial year to close on 30 June 2024 (2023-2024 financial year): the achievement of consolidated revenue of more than €150 million combined with an EBITDA margin of more than 3%. Recent progress is also in line with the ambitions announced for the 2025-2026 financial year, i.e. consolidated revenue of more than €300 million and an EBITDA margin of more than 12%.

Terms and conditions of the Global Offering

In accordance with the decisions taken by the Board of Directors held on 13 March 2024, the Global Offering will be carried out through two separate but concurrent offers: 

• A private placement with qualified investors in accordance with Article L. 411-2 of the French Monetary and Financial Code, in France and outside France, with the exception of certain countries, particularly the United States of America, according to the procedure known as the accelerated bookbuilding process (in accordance with the 10th resolution of the Combined General Meeting of 30 November 2023); and
• A public offering intended for individuals via the PrimaryBid platform (in accordance with the 9th resolution of the Combined General Meeting of 30 November 2023), which will be made on the basis of an allocation proportional to demand within the limit of the amount allocated to this public offering, with a reduction in allocations in the event of excess demand, under the same financial conditions as the Private Placement

The price per share of the Private Placement will be equal to a discount of 20% compared to the volume-weighted average price of the 2CRSi share over the last three trading sessions preceding the setting of the issue price (i.e. 11, 12 and 13 March 2024). The subscription price of the new shares under the PrimaryBid Offering will be equal to the price of the new shares offered under the Private Placement.

The amount of the Global Offering will depend exclusively on the orders received for each of the aforementioned components without the possibility of reallocating the amounts allocated from one to the other. It is specified that the PrimaryBid Offering intended for individuals is ancillary to the Private Placement and that it will represent a maximum of 20% of the amount of the Private Placement, up to a limit of €8 million. In any event, the PrimaryBid Offering will not be completed if the capital increase as part of the Private Placement is not completed. The Private Placement is not subject to the PrimaryBid Offering.

The accelerated bookbuilding process for the Private Placement will begin immediately after the publication of this press release and will end before the markets open on [14] March 2024, subject to early or late closure. The PrimaryBid will commence immediately and close today at 10:00 p.m. CET, subject to early closure.

The final number of shares to be issued will be decided by the Company's Chairman and Chief Executive Officer at the end of the Global Offering, by virtue of and within the limits of the sub-delegations of authority granted by the Board of Directors and in accordance with the 9th and 10th resolutions of the Combined General Meeting of 30 November 2023.

The settlement-delivery of the new ordinary shares to be issued as part of the Global Offering and their admission to trading on the Euronext Growth® Paris market are scheduled for 18 March 2024. The new shares will be of the same class and will be fungible with the existing shares, will benefit from all the rights attached to the existing shares and will be admitted to trading on the Euronext Growth® Paris market under the same ISIN code FR0013341781.

Subscription commitments

Prior to the launch of the Global Offering, Alain Wilmouth, shareholder, co-founder and CEO of 2CRSi, has irrevocably undertaken to place a subscription order in the Global Offering for a total amount of €950k, of which €650k by offsetting receivables via his holding company HAW (Holding Alain Wilmouth), and directly for an amount of €300k in cash, it being specified that the latter commitment could be reduced in the event of a strong oversubscription.

Michel Wilmouth, a shareholder and co-founder of 2CRSi, has irrevocably undertaken to place a subscription order in the context of the Global Offer, on a personal basis and by offsetting debts, for an amount of €50k. Together, these subscription commitments represent a total amount of €1 million.

Holding and lock-up commitments

As part of the Global Offering, the co-founding shareholders, Alain Wilmouth (co-founder and CEO of 2CRSi, directly and indirectly holding 59% of the share capital prior to the Global Offering, and Michel Wilmouth (co-founder of 2CRSi, holding 4.5% of the share capital prior to the Global Offering) reiterated their vision and commitment to 2CRSi by making a 270-day lock-up commitment for all the securities that they will hold after the Global Offering, subject to the usual exceptions.

In addition, the Company has undertaken not to issue shares or securities giving access to the capital for a period of 180 calendar days following the settlement-delivery date of the Global Offering, subject to certain usual exceptions.

Eligibility of the Global Offering for the 150-0 B ter scheme of the French General Tax Code (reinvestment of capital gains) and for the PEA and SME-ISE PEA

The Company is eligible for the provisions of Article 150-0 B ter of the French General Tax Code (reinvestment of proceeds from sale). Investors who may benefit from this regime should consult their usual tax adviser in order to assess their personal situation with regard to the specific applicable regulations.

Finally, the Company reiterates that it complies with the eligibility criteria for the SME-ISE PEA as specified by the provisions of Articles L. 221-32-2 and D.221-113-5 et seq. of the French Monetary and Financial Code. As a result, 2CRSi shares can be fully integrated into equity savings plans (PEAs) and PME-ISE PEA accounts, which enjoy the same tax benefits as a traditional PEA.

Intermediaries

Portzamparc – BNP Paribas Group and Gilbert Dupont – Societe Generale Group act as Global Coordinators & Joint Bookrunners.

Jeantet acts as legal advisor and SEITOSEI.ACTIFIN Financial & Corporate Communication as financial communication advisor.

Subscription to the PrimaryBid

As part of the PrimaryBid Offering, investors may only subscribe through the PrimaryBid partners mentioned on the PrimaryBid website (www.PrimaryBid.fr). The PrimaryBid Offering is not the subject of an placement contract. For more details, please visit the PrimaryBid website at www.PrimaryBid.fr.

Risk Factors

The public should be aware of the risk factors relating to 2CRSi and its business, presented in the 2022-2023 annual financial report published by the Company and available free of charge on the 2CRSi website. The occurrence of some or all of these risks may have an adverse impact on 2CRSi’s business, financial position, results, development or outlook. The risk factors presented in these documents are identical as of the date of this press release. 

Investors should also take into account the following specific risks:

• shareholders not participating in the Private Placement or the PrimaryBid Offering carried out at the same time will see their stake in the Company’s share capital diluted following these capital increases or in the event of a new call on the market to finance the Company’s growth;
• sales of the Company’s shares could occur on the market and could have an adverse impact on the market price of the Company’s shares. In particular, sales of the Company’s shares by significant shareholders of the Company could have an adverse impact on the market price of the Company’s shares;
• the market price of the Company’s shares may fluctuate and fall below the subscription price of the new shares; and
• the volatility and liquidity of the Company’s shares could fluctuate significantly.

Such events could have a material adverse effect on the market price of the Company’s shares.

Prospectus

The Global Offer does not give rise to a prospectus subject to the approval of the Autorité des marchés financiers.

This press release does not constitute a prospectus under Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended, or an offer to the public.